Introduction
Most patients with malignant pancreaticobiliary tumours present with obstructive jaundice requiring biliary decompression 1 . Left untreated, obstructive jaundice can lead to nutritional, metabolic and septic complications 2 . Biliary decompression can be achieved either endoscopically via ERCP or percutaneously via transhepatic biliary drainage (PTBD). PTBD is commonly performed when ERCP is unsuccessful. It is also an option in cases that preclude endoscopic access, such as patients with tumor infiltration and obstruction or those with surgically altered anatomy. It is also the intervention of choice in certain proximal malignant pancreaticobiliary obstruction 3, 4 . External Percutaneous Transhepatic Biliary Drainage (EPTBD), is when the catheter tip is placed proximal to the level of obstruction ( Figure 1 ). Internal-external Percutaneous Transhepatic Biliary Drainage (IEPTBD), is when the catheter is passed beyond the level of obstruction and the catheter tip is placed in the second part of duodenum (Figure 2 ). Biliary drainage is achieved externally in EPTBD and mainly internally albeit some external drainage in IEPTBD.
A retrospective study, approval from national Medical Research and Ethics Committee (MREC). Patients who presented to Sarawak General Hospital between 2011 until 2016 with malignant pancreaticobiliary obstruction between the ages of 18 to 80-years old were included, irrespective of resectability. The diagnosis was based on either radiological imagings, supported by tumor markers or confirmed by histopathological examination (HPE).
Definition
Cholangitis is defined according to Tokyo Guidelines 2013. Sepsis is defined according to American College of Chest Physician and Society of Critical Care Medicine Consensus 1992. Successful drainage was defined as 20% reduction in serum total bilirubin level from baseline within 7 days duration 5 . Proximal obstruction is defined as above the insertion of cystic duct and distal obstruction is defined as below the insertion of cystic duct 3 .
93 patients with malignant pancreaticobiliary obstruction were included in this study. Table 1 shows the baseline characteristics. 49 patients were male. Mean age was 63 years. All patients had CT scan as part of the diagnosis workup. The radiological diagnosis was supported by elevated tumour markers in 24 cases and confirmed by HPE in 35 cases. No difference in effectiveness of biliary drainage and post-procedural cholangitis and sepsis between EPTBD and IEPTBD. Our studies showed higher percentage of post-procedural cholangitis (60.2%) and sepsis (35.5%) compared to other series. IEPTBD is 10% and 15% higher than EPTBD to develop post-procedural cholangitis and postprocedural sepsis, respectively.
Conclusions
There is no significant difference between EPTBD and IEPTBD in effectiveness of biliary drainage, post-procedural cholangitis and sepsis. However, there is significant difference in post-procedural complications. Thus, EPTBD is recommended as the preferred intervention for patients with malignant pancreaticobiliary obstruction requiring percutaneous intervention. EPTBD may be less deleterious to certain high risk group, namely, the elderly, patients with proximal obstruction and those with preprocedural cholangitis and sepsis. Results from this study are relevant toward implementation of safe and effective management of malignant pancreaticobiliary obstruction and ultimately lead to better patient outcomes.
Comparison for unsuccessful drainage that proceeded to developed sepsis between EPTBD group and IEPTBD group showed approximately 27% more developed post-procedural sepsis after unsuccessful drainage in the IEPTBD group but it was not statistically significant (p value = 0.08). 
